Abcellera Biologics is trading 4.3% up at $13.08 in pre-market on October 12; the cause remains unclear. - No fresh company announcement or reliable report directly explains the move. - An October 8 announcement outlined an upcoming ABCL635 data presentation, but it is not evidence of a new catalyst today. - A broader biotech rally was reported in the previous session, but October 12 market context shows only modest index gains, with no current sector move confirming that explanation. Pre-market trading can be thin; no volume figures were provided.